Bloomberg reported that Baxalta Inc. (NYSE: BXLT) ended discussions to
acquire Ariad Pharmaceuticals Inc. (Nasdaq: ARIA). Shares of Baxalta
added 4 cents to $34.65 while Ariad Pharmaceuticals stock dropped $1.78
to $7.32.
Baxalta ends acquisition talks with Ariad
September 02, 2015 at 12:57 PM EDT